Global Acromegaly and Gigantism Treatment market- Analysis by Treatment Type, End-users and Region, Growth and Forecast-2019-2027

The Global Market for Acromegaly and Gigantism treatment was worth $1.4 Bn in 2019 and is expected to grow at a CAGR of 4.4% in the forecast period, reaching a value of $2.2 Bn.

Global Acromegaly and Gigantism Treatment market Introduction and Overview

Acromegaly is a rare and severe disease caused by an increased, autonomous secretion of the Growth Hormone (GH), resulting in high circulating levels of insulin-like growth factor 1 (IGF-1). The comorbidities and mortality rate are closely related to the disease duration. The current treatment for acromegaly includes neurosurgery, radiotherapy and medical therapy. Transsphenoidal surgery often represents the recommended first-line treatment. Gigantism is a rare condition that causes abnormal growth in human beings. A tumour in the pituitary gland is the major reason for the condition to occur. The abnormal growth is notable in terms of height as well as girth of the body. Common symptoms for the early diagnosis of this disease include- very large hand and feet, thick toes and fingers and coarse facial features. Acromegaly and gigantism is a rare disease prevailing 2.8 to 13.7 cases per 1 lakh people. The increasing prevalence of the disease is the major factor driving the market growth. Rise in other chronic disorders such as carney complex and development of novel therapy treatments are also aiding the market growth. The first-generation somatostatin receptor ligands (SRLs) are the drug choice in patients after surgery. Other available drugs approved for clinical use are the second-generation SRL pasireotide, Dopamine agonist- Cabergoline and the GH-receptor antagonist Pegvisomant. The increase in patient number and demand for medications to cure the disease is fuelling the market growth. According to the American cancer Society, around ten thousand pituitary tumors are diagnosed each year in America. Also, strong pipelines for drugs, increasing awareness, changing lifestyles and increasing investments in R&D for developing new therapeutics are driving the market upwards. The report covers the detailed analysis of global market for Acromegaly and Gigantism treatment with the classifications of the market based on treatment type, end-user and region. Analysis of past market dynamics from 2016 to 2019 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it. The report has profiled seven key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques. Report has come up with recommendations for future hot spot in APAC region. New research findings, funding policies for projects and its impact on Acromegaly and Gigantism treatment market are covered in the report Global Acromegaly and Gigantism Treatment market To know about the Research Methodology :- Request Free Sample Report

Global Acromegaly and Gigantism Treatment market Segment Analysis

Somatostatin Analogs is expected to hold the major market share of xx% Somatostatin analogs segment (SSAs) accounted for the largest market share in revenue terms in 2019. SSAs have been prescribed as the first line of treatment for acromegaly and gigantism by physicians. The currently available marketed drugs are Sandostatin LAR, Signifor LAR and Somatuline. Novartis and Ipsen Pharma are the key players who developed and marketed the drugs, contributing to the market growth. A strong pipeline of drugs is expected to fuel up the market growth in forecast period. Many more drugs are under clinical trials and are expected to be approved soon. Currently, two GHRIs are in the pipeline such as ISIS 766720 by Ionis pharmaceuticals. It is undergoing a phase II clinical trial and is expected to soon get approved by the FDA.

Global Acromegaly and Gigantism Treatment market segmentation

The Global Market for Acromegaly and Gigantism treatment is segmented based on-

Treatment Type

• Surgery • Radiation therapy • Medication  Somatostatin analogs  GH Receptor Antagonists  Dopamine Antagonists

End Users

• Hospitals • Clinics • Home Care

Scope of Global Acromegaly and Gigantism Treatment market: Inquire before buying

Global Acromegaly and Gigantism Treatment market Regional Insights

Global Acromegaly and Gigantism Treatment market1 North America generated a revenue of $xx Mn in 2019 and is expected to emerge as a dominant region in the forecast period. Increasing prevalence of the disease, growing research activities, advanced treatment techniques, favourable reimbursement policies, development of novel products are the multiple factors boosting the growth of market in this region. Moreover, the efforts of key players in developing new and efficient drug pipelines is boost the regional demand for market. Asia Pacific is expected to witness growth in the forecast period. Owing to the increasing population and rising diabetic cases, growing healthcare facilities in developing nations and advanced treatment options, the market in this region is anticipated to grow. Sun Pharma and WOCKHARDT are developing new formulations for octreotide molecule and is currently in the pre-clinical phase. The approval of this is expected to exhibit a major hike in the APAC market.

Key players operating the Global Acromegaly and Gigantism Treatment Market

• Pfizer Inc • Chiasma Inc • Novartis AG • Crinetics Pharmaceuticals • Ionis Pharmaceuticals Inc • Midatech Pharma Inc • Validus Pharmaceuticals LLC The report also helps in understanding Global Acromegaly and Gigantism Treatment Market dynamics, structure by analysing the market segments and project the Global Acromegaly and Gigantism Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Acromegaly and Gigantism Treatment Market make the report investor’s guide.
Global Acromegaly and Gigantism Treatment market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: ACROMEGALY AND GIGANTISM TREATMENT Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global ACROMEGALY AND GIGANTISM TREATMENT Market Analysis and Forecast 6.1. ACROMEGALY AND GIGANTISM TREATMENT Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global ACROMEGALY AND GIGANTISM TREATMENT Market Analysis and Forecast, By Treatment Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Treatment Type 7.4. ACROMEGALY AND GIGANTISM TREATMENT Market Size (US$ Mn) Forecast, By Treatment Type 7.5. ACROMEGALY AND GIGANTISM TREATMENT Market Analysis, By Treatment Type 7.6. ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis, By Treatment Type 8. Global ACROMEGALY AND GIGANTISM TREATMENT Market Analysis and Forecast, By End Users 8.1. Introduction and Definition 8.2. Key Findings 8.3. ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By End Users 8.4. ACROMEGALY AND GIGANTISM TREATMENT Market Size (US$ Mn) Forecast, By End Users 8.5. ACROMEGALY AND GIGANTISM TREATMENT Market Analysis, By End Users 8.6. ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis, By End Users 9. Global ACROMEGALY AND GIGANTISM TREATMENT Market Analysis, By Region 9.1. ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Region 9.2. ACROMEGALY AND GIGANTISM TREATMENT Market Size (US$ Mn) Forecast, By Region 9.3. ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis, By Region 10. North America ACROMEGALY AND GIGANTISM TREATMENT Market Analysis 10.1. Key Findings 10.2. North America ACROMEGALY AND GIGANTISM TREATMENT Market Overview 10.3. North America ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Treatment Type 10.4. North America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 10.4.1. Surgery 10.4.2. Radiation therapy 10.4.3. Medication 10.5. North America ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By End Users 10.6. North America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 10.6.1. Hospitals 10.6.2. Clinics 10.6.3. Home Care 10.7. North America ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Country 10.8. North America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America ACROMEGALY AND GIGANTISM TREATMENT Market Analysis, By Country 10.10. U.S. ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 10.10.1. Surgery 10.10.2. Radiation therapy 10.10.3. Medication 10.11. U.S. ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 10.11.1. Hospitals 10.11.2. Clinics 10.11.3. Home Care 10.12. Canada ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 10.12.1. Surgery 10.12.2. Radiation therapy 10.12.3. Medication 10.13. Canada ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 10.13.1. Hospitals 10.13.2. Clinics 10.13.3. Home Care 10.14. Mexico ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 10.14.1. Surgery 10.14.2. Radiation therapy 10.14.3. Medication 10.15. Mexico ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 10.15.1. Hospitals 10.15.2. Clinics 10.15.3. Home Care 10.16. North America ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis 10.16.1. By Treatment Type 10.16.2. By End Users 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Analysis 11.1. Key Findings 11.2. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Overview 11.3. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Treatment Type 11.4. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.4.1. Surgery 11.4.2. Radiation therapy 11.4.3. Medication 11.5. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By End Users 11.6. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.6.1. Hospitals 11.6.2. Clinics 11.6.3. Home Care 11.7. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Country 11.8. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.9.1. Surgery 11.9.2. Radiation therapy 11.9.3. Medication 11.10. Germany ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.10.1. Hospitals 11.10.2. Clinics 11.10.3. Home Care 11.11. U.K. ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.11.1. Surgery 11.11.2. Radiation therapy 11.11.3. Medication 11.12. U.K. ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.12.1. Hospitals 11.12.2. Clinics 11.12.3. Home Care 11.13. France ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.13.1. Surgery 11.13.2. Radiation therapy 11.13.3. Medication 11.14. France ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.14.1. Hospitals 11.14.2. Clinics 11.14.3. Home Care 11.15. Italy ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.15.1. Surgery 11.15.2. Radiation therapy 11.15.3. Medication 11.16. Italy ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.16.1. Hospitals 11.16.2. Clinics 11.16.3. Home Care 11.17. Spain ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.17.1. Surgery 11.17.2. Radiation therapy 11.17.3. Medication 11.18. Spain ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.18.1. Hospitals 11.18.2. Clinics 11.18.3. Home Care 11.19. Sweden ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.19.1. Surgery 11.19.2. Radiation therapy 11.19.3. Medication 11.20. Sweden ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.20.1. Hospitals 11.20.2. Clinics 11.20.3. Home Care 11.21. CIS countries ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.21.1. Surgery 11.21.2. Radiation therapy 11.21.3. Medication 11.22. CIS countries ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.22.1. Hospitals 11.22.2. Clinics 11.22.3. Home Care 11.23. Rest of Europe ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 11.23.1. Surgery 11.23.2. Radiation therapy 11.23.3. Medication 11.24. Rest of Europe ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 11.24.1. Hospitals 11.24.2. Clinics 11.24.3. Home Care 11.25. Europe ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis 11.25.1. By End Users 11.25.2. By Treatment Type 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Analysis 12.1. Key Findings 12.2. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Overview 12.3. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Treatment Type 12.4. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.4.1. Surgery 12.4.2. Radiation therapy 12.4.3. Medication 12.5. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By End Users 12.6. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.6.1. Hospitals 12.6.2. Clinics 12.6.3. Home Care 12.7. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Country 12.8. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Analysis, By Country 12.10. China ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.10.1. Surgery 12.10.2. Radiation therapy 12.10.3. Medication 12.11. China ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.11.1. Hospitals 12.11.2. Clinics 12.11.3. Home Care 12.12. India ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.12.1. Surgery 12.12.2. Radiation therapy 12.12.3. Medication 12.13. India ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.13.1. Hospitals 12.13.2. Clinics 12.13.3. Home Care 12.14. Japan ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.14.1. Surgery 12.14.2. Radiation therapy 12.14.3. Medication 12.15. Japan ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.15.1. Hospitals 12.15.2. Clinics 12.15.3. Home Care 12.16. South Korea ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.16.1. Surgery 12.16.2. Radiation therapy 12.16.3. Medication 12.17. South Korea ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.17.1. Hospitals 12.17.2. Clinics 12.17.3. Home Care 12.18. Australia ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.18.1. Surgery 12.18.2. Radiation therapy 12.18.3. Medication 12.19. Australia ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.19.1. Hospitals 12.19.2. Clinics 12.19.3. Home Care 12.20. ASEAN ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.20.1. Surgery 12.20.2. Radiation therapy 12.20.3. Medication 12.21. ASEAN ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.21.1. Hospitals 12.21.2. Clinics 12.21.3. Home Care 12.22. Rest of Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 12.22.1. Surgery 12.22.2. Radiation therapy 12.22.3. Medication 12.23. Rest of Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 12.23.1. Hospitals 12.23.2. Clinics 12.23.3. Home Care 12.24. Asia Pacific ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis 12.24.1. By Treatment Type 12.24.2. By End Users 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Analysis 13.1. Key Findings 13.2. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Overview 13.3. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Treatment Type 13.4. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 13.4.1. Surgery 13.4.2. Radiation therapy 13.4.3. Medication 13.5. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By End Users 13.6. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 13.6.1. Hospitals 13.6.2. Clinics 13.6.3. Home Care 13.7. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Country 13.8. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Analysis, By Country 13.10. GCC Countries ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 13.10.1. Surgery 13.10.2. Radiation therapy 13.10.3. Medication 13.11. GCC Countries ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 13.11.1. Hospitals 13.11.2. Clinics 13.11.3. Home Care 13.12. South Africa ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 13.12.1. Surgery 13.12.2. Radiation therapy 13.12.3. Medication 13.13. South Africa ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 13.13.1. Hospitals 13.13.2. Clinics 13.13.3. Home Care 13.14. Nigeria ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 13.14.1. Surgery 13.14.2. Radiation therapy 13.14.3. Medication 13.15. Nigeria ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 13.15.1. Hospitals 13.15.2. Clinics 13.15.3. Home Care 13.16. Egypt ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 13.16.1. Surgery 13.16.2. Radiation therapy 13.16.3. Medication 13.17. Egypt ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 13.17.1. Hospitals 13.17.2. Clinics 13.17.3. Home Care 13.18. Rest of Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 13.18.1. Surgery 13.18.2. Radiation therapy 13.18.3. Medication 13.19. Rest of Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 13.19.1. Hospitals 13.19.2. Clinics 13.19.3. Home Care 13.20. Middle East & Africa ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis 13.20.1. By Treatment Type 13.20.2. By End Users 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America ACROMEGALY AND GIGANTISM TREATMENT Market Analysis 14.1. Key Findings 14.2. South America ACROMEGALY AND GIGANTISM TREATMENT Market Overview 14.3. South America ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Treatment Type 14.4. South America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 14.4.1. Surgery 14.4.2. Radiation therapy 14.4.3. Medication 14.5. South America ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By End Users 14.6. South America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 14.6.1. Hospitals 14.6.2. Clinics 14.6.3. Home Care 14.7. South America ACROMEGALY AND GIGANTISM TREATMENT Market Value Share Analysis, By Country 14.8. South America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America ACROMEGALY AND GIGANTISM TREATMENT Market Analysis, By Country 14.10. Brazil ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 14.10.1. Surgery 14.10.2. Radiation therapy 14.10.3. Medication 14.11. Brazil ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 14.11.1. Hospitals 14.11.2. Clinics 14.11.3. Home Care 14.12. Colombia ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 14.12.1. Surgery 14.12.2. Radiation therapy 14.12.3. Medication 14.13. Colombia ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 14.13.1. Hospitals 14.13.2. Clinics 14.13.3. Home Care 14.14. Argentina ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 14.14.1. Surgery 14.14.2. Radiation therapy 14.14.3. Medication 14.15. Argentina ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 14.15.1. Hospitals 14.15.2. Clinics 14.15.3. Home Care 14.16. Rest of South America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By Treatment Type 14.16.1. Surgery 14.16.2. Radiation therapy 14.16.3. Medication 14.17. Rest of South America ACROMEGALY AND GIGANTISM TREATMENT Market Forecast, By End Users 14.17.1. Hospitals 14.17.2. Clinics 14.17.3. Home Care 14.18. South America ACROMEGALY AND GIGANTISM TREATMENT Market Attractiveness Analysis 14.18.1. By Treatment Type 14.18.2. By End Users 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, End Users, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and End Users 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Pfizer Inc 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Chiasma Inc 15.3.3. Novartis AG 15.3.4. Crinetics Pharmaceuticals 15.3.5. Ionis Pharmaceuticals Inc 15.3.6. Midatech Pharma Inc 15.3.7. Validus Pharmaceuticals LLC

About This Report

Report ID 82292
Category Healthcare
Published Date February 2021
Updated Date
Contact Us